Development and evaluation of hydrophilic colloid matrix of famotidine tablets

AAPS PharmSciTech

Volumn 11, Issue 2, 2010, Pages 708-718

  Shoaib, Muhammad Harris ^a   Al Sabah Siddiqi, Saniah ^b   Yousuf, Rabia Ismail ^a   Zaheer, Kamran ^c   Hanif, Muhammad ^a   Rehana, Saeed ^a   Jabeen, Sabahat ^a  

^a UNIVERSITY OF KARACHI   (Pakistan)

^b FEDERAL URDU UNIVERSITY OF ARTS   (Pakistan)

^c HAMDARD UNIVERSITY   (Pakistan)

Author keywords

Famotidine; Hydrophilic colloid matrix; Hydroxypropyl methylcellulose (HPMC); Kinetics; Sustained release

Indexed keywords

AEROSIL; FAMOTIDINE; HYDROXYPROPYLMETHYLCELLULOSE; POLYMER; TALC; CELLULOSE; COLLOID; DELAYED RELEASE FORMULATION; EXCIPIENT; MICROCRYSTALLINE CELLULOSE; TABLET;

ARTICLE; CLINICAL EVALUATION; COLLOID; DIFFUSION; DISSOLUTION; DRUG FORMULATION; HARDNESS; HYDROPHILICITY; IN VITRO STUDY; PHYSICAL PARAMETERS; PRIORITY JOURNAL; SUSTAINED DRUG RELEASE; TABLET; TABLET FRIABILITY; THICKNESS; WEIGHT; CHEMICAL PHENOMENA; CHEMISTRY; DELAYED RELEASE FORMULATION; EVALUATION STUDY; PROCEDURES; SYNTHESIS;

CELLULOSE; COLLOIDS; DELAYED-ACTION PREPARATIONS; DRUG COMPOUNDING; EXCIPIENTS; FAMOTIDINE; HYDROPHOBICITY; TABLETS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS;

EID: 77954797272     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-010-9427-7     Document Type: Article

References (32)

1. Dollery C. Therapeutic drugs. 2nd ed. Edinburgh: Churchill Livingstone; 1999.
2. Pepsid. Electronic medicines compendium. Aventis Pharma Ltd. http://emc.medicines.org.uk/emc/assets/c/html/display.doc. Accessed 01 Aug. 2003.
3. Alderman DA. A review of cellulose ethers in hydrophilic matrices for oral controlled-release dosage forms. Int J Pharm Technol Prod Manuf. 1984;5:1-9.
4. Reza MS, Quadir MA, Haid SS. Comparative evaluation of plastic hydrophobic and hydrophilic polymers as matrices for controlled release drug delivery. J Pharm Pharm Sci. 2003;6(2):274-91.
5. Gothoskar AV. Study of effect of polymer viscosity and polymer: excipient ratio on drug-release patterns from swellable matrices. Drug Delivery Technology. 2005;5:1-7.
6. VIVAPHARM, cellulose-based polymer for film-coating and sustained-release application. http://www.jrspharma.de/. Accessed 01 Aug. 2005.
7. Rawlins EA. Bentley's textbook of pharmaceutics. 8th ed. UK: Baillieve Tindall; 1986.
8. British pharmacopoeia. London: Stationary Office London; 2004.
9. Gad SC. Pharmaceutical manufacturing handbook. New York: Wiley; 2008.
10. United States pharmacopoeia 23. Rockville: US Pharmacopeial Convention; 1995.
11. Hanson WA. Handbook of dissolution testing: compendial method. USA: Pharmaceutical Technology Publication; 1982.
12. Hadjiioannou TP, Christian GD, Koupparis MA, Macheras PE. Quantitative calculations in pharmaceutical practice and research. New York: VCH; 1993.
13. Bourne DW. Pharmacokinetics. In: Banker GS, Rhodes CT, editors. Modern pharmaceutics. 4th ed. New York: Marcel Dekker; 2002. p. 66-91.
14. Higuchi T. Mechanism of sustained action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci. 1963;52:1145-9.
15. Hixson AW, Crowell JH. Dependence of reaction velocity upon surface and agitation theoretical consideration. Ind Eng Chem. 1931;23:923-31.
16. Korsmeyer RW, Gurny R, Doelker E, Buri P, Peppas NA. Mechanisms of solute release from porous hydrophilic polymers. Int J Pharm. 1983;15:25-35.
17. Langenbucher F. Linearization of dissolution curves by the Weibull distribution. J Pharm Pharmacol. 1972;24:979-81.
18. Costa P, Sousa Lobo MJ. Modeling and comparison of dissolution profile. Eur J Pharm Sci. 2001;13:123-33.
19. Baker RW, Lonsdale HS. Controlled release: mechanism and rates. Controlled release of biologically active agents. New York: Plenum; 1974. p. 15-71.
20. Ritger LP, Peppas NA. A simple equation for description of solute release 1. Fickian and anomalous release from swellable devices. J Control Release. 1987;5:37-42.
21. Tiwari SB, Rajabi-Siahboomi AR. Applications of complementary polymers in HPMC hydrophilic extended release matrices. Drug Deliv Tech. 2009;9(7):20-7.
22. Barakat NS, Elbagory IM, Almurshedi AS. Controlled-release carbamazepine matrix granules and tablets comprising lipophilic and hydrophilic components. Drug Deliv. 2009;16(1):57-65.
23. Tajarobi F, Abrahmsén-Alami S, Hansen M, Larsson A. The impact of dose and solubility of additives on the release from HPMC matrix tablets-identifying critical conditions. Pharm Res. 2009;26(6):1496-503.
24. Dow Excipients. Technical presentations. http://www.dow.com/ dowexcipients/resources/product/methocel/meth-presentations.htm (2009). Accessed 31 May 2009.
25. Saravanan M, Nataraj KS, Ganesh KS. Hydroxypropyl methyl cellulose based cephalexin extended release tablets: influence of tablet formulation, hardness and storage on in vitro release kinetics. Chem Pharm Bull. 2003;51(8):978-83.
26. Bravo SA, Lamas MA, Salomon CJ. In-vitro studies of diclofenac sodium controlled-release from biopolymeric hydrophilic matrices. J Pharm Sci. 2002;5(3):213-9.
27. Talukdar MM, Plaizier-vercammen J. Evaluation of xanthan gum as a hydrophilic matrix for controlled release dosage forms preparations. Drug Dev Ind Pharm. 1993;19:1037-46.
28. Shato H, Miyagawa Y, Okabe T, Miyajima M, Sunada H. Dissolution mechanism of diclofenac sodium from wax matrix granules. J Pharm Sci. 1997;86(8):929-34.
29. Hakim M. Evaluation of a new rate retarding polymer Kollidon SR as matrix tablets. M. Pharm. thesis, Bangladesh, DU; 2001.
30. Patel N, Chotai N, Patel J, Soni T, Desai J, Patel R. Comparison of in-vitro dissolution profiles of oxcarbazepine-HP β-CD tablet formulations with marketed oxcarbazepine tablets. http://www.dissolutiontech.com (2008). Accessed 18 Jan 2009.
31. Karmakar AB, Gonjari ID, Hosmani AH, Dhabale PN, Bhise SB. Dissolution rate enhancement of fenofibrate using liquisolid tablet technique. Part II: evaluation of in vitro dissolution profile comparison method. Lat Am J Pharm. 2009;28(2):219-25.
32. Yuksel N, Kanik AE, Baykara T. Comparison of in vitro dissolution profiles by ANOVA based model dependent and independent methods. Int J Pharm. 2009;209:56-67.